XML 54 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Payments (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2013
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2012
Share-Based Payments [Abstract]        
Stock option amortization $ 164,000 [1] $ 163,000 [1]    
Stock issued for service 79,000 [2] 0 [2]    
Stock warrants issued for service 108,000 [3] 12,000 [3]    
Total share based payments expense 351,000 175,000    
Fair Value Assumptions and Methodology [Abstract]        
Risk-free interest rate minimum (in hundredths) 1.73%      
Risk free interest rate maximum (in hundredths) 1.98%      
Expected volatility minimum (in hundredths) 75.00%      
Expected life 10 years      
Expected dividend yield (in hundredths) 0.00%      
Number of Independent Members Appointed to Board of Directors       2
Number of Independent Directors Granted Restricted Shares       3
Restricted shares granted (in shares)       10,000
Vesting period 1 year      
Marketing expenses 44,000   12,000  
Prepaid compensation expenses 193,000   0  
Number of shares authorized (in shares) 4,000,000      
Stock option activity, weighted average exercise price [Roll Forward]        
Options outstanding at beginning of year (in dollars per share) $ 3.54      
Granted (in dollars per share)       $ 0
Exercised (in dollars per share)       $ 0
Cancelled/expired (in dollars per share)       $ 45.00
Options outstanding at end of period (in dollars per share) $ 3.55     $ 3.54
Options exercisable at end of period (in dollars per share) $ 3.30      
Stock option activity, aggregate intrinsic value [Roll forward]        
Total unrecognized compensation expense related to options granted 1,243,000      
Unrecognized compensation expense related to options grant, recognition period 3 years      
Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Nonvested, Weighted Average Grant Date Fair Value at Beginning of Year (in dollars per share) $ 3.67      
Granted (in dollars per share) $ 0.00      
Vested (in dollars per share) $ 3.45      
Canceled (in dollars per share) $ 45.00      
Nonvested, Weighted Average Grant Date Fair Value at End of Year (in dollars per share $ 3.62     $ 3.67
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]        
Number Outstanding (in shares) 1,584,501      
Contractual Life 7 years 10 months 6 days      
Weighted Average Exercise Price (in dollars per share) $ 3.41      
Number Exercisable (in shares) 1,131,160      
Exercisable, Weighted Average Exercise Price (in shares) $ 3.30      
Class of Warrant or Right [Line Items]        
Weighted average exercise price of warrants (in dollars per share) $ 4.37      
Weighted average remaining life     4 years 3 months 4 days  
Number of warrants outstanding (in shares) 1,367,063     1,348,975
Share Exchange Consulting Warrants ($45.00 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares)       59,664
Exercise price (in dollars per share) $ 45.00      
Expiration Date Jan. 11, 2013      
2007 Private Placement Broker Warrants ($45.00 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares)       8,533
Exercise price (in dollars per share) $ 45.00      
Expiration Date Jan. 11, 2013      
2007 Private Placement Investor Warrants ($150.00 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares)       53,333
Exercise price (in dollars per share) $ 150.00      
Expiration Date Jan. 11, 2013      
July 2010 Sinotop Acquisition Warrants ($45.00 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares)       17,049
Exercise price (in dollars per share) $ 45.00      
Expiration Date Jan. 11, 2013      
July 2010 Sinotop Acquisition Warrants ($150.00 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares)       13,333
Exercise price (in dollars per share) $ 150.00      
Expiration Date Jan. 11, 2013      
May 2011 Warner Brothers Warrants ($6.60 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares) 200,000     200,000
Exercise price (in dollars per share) $ 6.60      
Expiration Date May 11, 2016      
2011 Service Agreement Warrants ($7.20 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares) 23,333     20,000
Exercise price (in dollars per share) $ 7.20      
Expiration Date Jun. 15, 2016      
2012 August Financing Warrants ($4.25 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares) 977,063     977,063
Exercise price (in dollars per share) $ 4.25      
Expiration Date Aug. 30, 2017      
2013 Service Agreement Warrants ($2.00 exercise price) [Member]
       
Class of Warrant or Right [Line Items]        
Number of warrants outstanding (in shares) 166,667      
Exercise price (in dollars per share) $ 2.00      
Expiration Date Feb. 26, 2018      
$3 - $4 [Member]
       
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]        
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 3      
Range of Exercise Prices, Upper Range Limit (in dollars per share $ 4      
Number Outstanding (in shares) 1,338,000      
Contractual Life 7 years 11 months 1 day      
Weighted Average Exercise Price (in dollars per share) $ 3.04      
Number Exercisable (in shares) 1,050,028      
Exercisable, Weighted Average Exercise Price (in shares) $ 3.04      
$4 - $8 [Member]
       
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]        
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 4      
Range of Exercise Prices, Upper Range Limit (in dollars per share $ 8      
Number Outstanding (in shares) 243,168      
Contractual Life 8 years 8 months 12 days      
Weighted Average Exercise Price (in dollars per share) $ 6.43      
Number Exercisable (in shares) 77,799      
Exercisable, Weighted Average Exercise Price (in shares) $ 6.60      
$8 - $33 [Member]
       
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]        
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 8      
Range of Exercise Prices, Upper Range Limit (in dollars per share $ 33      
Number Outstanding (in shares) 0      
Weighted Average Exercise Price (in dollars per share) $ 0.00      
Number Exercisable (in shares) 0      
Exercisable, Weighted Average Exercise Price (in shares) $ 0      
$33 - $74 [Member]
       
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]        
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 33      
Range of Exercise Prices, Upper Range Limit (in dollars per share $ 74      
Number Outstanding (in shares) 2,000      
Contractual Life 2 months 16 days      
Weighted Average Exercise Price (in dollars per share) $ 33.75      
Number Exercisable (in shares) 2,000      
Exercisable, Weighted Average Exercise Price (in shares) $ 33.75      
$74 to $75 [Member]
       
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]        
Range of Exercise Prices, Lower Range Limit (in dollars per share) $ 74      
Range of Exercise Prices, Upper Range Limit (in dollars per share $ 75      
Number Outstanding (in shares) 1,333      
Contractual Life 4 years 11 months 12 days      
Weighted Average Exercise Price (in dollars per share) $ 75.00      
Number Exercisable (in shares) 1,333      
Exercisable, Weighted Average Exercise Price (in shares) $ 75.00      
Stock Options [Member]
       
Fair Value Assumptions and Methodology [Abstract]        
Common shares issued for service (in shares) 196,620      
Number of shares authorized (in shares) 1,584,501     1,585,401
Shares vested (in shares) 210,010      
Prepaid compensation expenses $ 64,000      
Stock option activity, shares [Roll Forward]        
Options outstanding at beginning of year (in shares) 1,585,401      
Granted (in shares)       0
Exercised (in shares)       0
Cancelled/expired (in shares)       (900)
Options outstanding at end of period (in shares) 1,584,501     1,585,401
Options exercisable at end of period (in shares) 1,131,160      
Options available for issuance at December 31, 2012 (in shares) 2,415,499      
Non-vested Options [Member]
       
Fair Value Assumptions and Methodology [Abstract]        
Number of shares authorized (in shares) 459,840      
Stock option activity, shares [Roll Forward]        
Options outstanding at beginning of year (in shares) 525,396      
Granted (in shares) 0      
Vested (in shares) (64,656)      
Cancelled/expired (in shares) (900)      
Options outstanding at end of period (in shares) 459,840      
2010 Stock Incentive Plan [Member]
       
Fair Value Assumptions and Methodology [Abstract]        
Number of shares authorized (in shares) 4,000,000      
Stock option activity, shares [Roll Forward]        
Options outstanding at end of period (in shares) 4,000,000      
Warrant [Member]
       
Fair Value Assumptions and Methodology [Abstract]        
Common shares issued for service (in shares) 166,677      
Shares vested (in shares) 3,333      
[1] (a)The Company accounts for its stock option awards pursuant to the provisions of ASC 718, Stock Compensation. The fair value of each option award is estimated on the date of grant using the Black-Scholes Merton valuation model. The Company recognizes the fair value of each option as compensation expense ratably using the straight-line attribution method over the service period, which is generally the vesting period. The Black-Scholes Merton model incorporated the following assumptions for the options granted in 2012: risk-free interest rate of 1.73% to 1.98%, expected volatility of 75%, expected life of 10.0 years and expected dividend yield of 0%. There have been no options granted in 2013.
[2] (b)During 2012, the Company appointed two new "independent" (as defined under the NASDAQ listing requirements) members to the Board of Directors. In connection with the appointment we granted each of our three "independent" directors 10,000 restricted shares to be vested quarterly over one year. Also, during 2012, the Company granted 196,620 shares to certain consultants and Directors for services. As of March 31, there were 210,010 shares vested. We recorded the common shares at the closing price on the issue date and expensed to consulting and marketing services $193,000 during the three months ended March 31, 2013 (none in 2012).
[3] (c)In 2013, we issued 166,677 consulting warrants and 3,333 warrants vested during the period. The fair value of the warrants was estimated on the date of grant using the Black-Scholes Merton valuation model. We expensed to marketing $44,000 during the three months ended March 31, 2013 and recorded $64,000 to prepaid expense to be recognized for services provided in the remainder of 2013. For the three months ended March 31, 2012, we recorded $12,000 for marketing services.